As the RSV season approaches, families and healthcare providers must navigate the timing of maternal vaccination and infant antibody shots to best protect newborns from severe illness, with new guidelines highlighting the importance of synchronising these protective measures.
For families expecting a baby this autumn, protection against respiratory syncytial virus is becoming a timetable issue as much as a medical one. There are two main ways to shield infants from severe RSV illness: a single maternal dose of Pfizer’s Abrysvo during pregnancy, or a long-acting antibody given to the baby after birth. According to the Centres for Disease Control and Prevention, most infants do not need both.
The CDC recommends Abrysvo for pregnant patients between 32 and 36 weeks’ gestation, ideally during the RSV season from September through January in most of the United States. The aim is to pass protective antibodies to the baby before birth, giving early cover during the months when RSV hits hardest. For infants who are not protected through maternal vaccination, the CDC advises a separate antibody shot, such as nirsevimab or clesrovimab, after delivery.
The reason timing matters is that RSV remains a leading cause of hospital admission in young babies. MedicalDaily noted that the virus sends roughly two to three in every 100 infants under three months old to hospital each year, and the CDC says the first months of life are the period of greatest risk. In a CDC analysis of the 2024 to 2025 season, RSV-associated hospitalisation rates among babies aged 0 to 7 months were lower than prepandemic levels in two surveillance systems, with the steepest drops seen in infants aged 0 to 2 months. A separate study from the University of Pittsburgh and UPMC, published in JAMA Network Open, estimated 68% effectiveness for maternal vaccination against RSV hospitalisation in babies younger than three months.
That evidence is useful, but the practical decision still depends on the calendar. The CDC says infants born within 14 days of a maternal vaccination should also receive the infant antibody, while babies born at least 14 days after the mother’s dose usually do not need it. For families, the best next step is to ask the obstetrician or paediatrician which option fits the due date, where the vaccine will be given, and whether the birth hospital stocks the infant antibody.
Parents should also know what protection does not do. RSV can still infect a baby, and early warning signs include poor feeding, faster or harder breathing, chest retractions, wheezing, blue lips, fewer wet nappies or pauses in breathing. Any of those in a very young infant needs urgent medical attention. The good news is that, when the timing is right, today’s RSV tools can greatly reduce the chance that a baby’s first winter becomes a hospital stay.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
